Total Funding
89
59
Total FundingSeries D raised
Growth Score 89 in past quarter
-1 pts
Heat Score 59 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
44063
Gene+ is a genetic testing and precision oncology company that provides gene testing services for cancer prevention.
- Yang Ling: President and Chief Executive Officer
- Yi Xin: Chairman and Chief Technology Officer
About the Company
Gene+ is a genetic testing and precision oncology company that provides gene testing services for cancer prevention. The company claims to operate in around 100 hospitals and has served thousands of cancer patients in China.